Endocrinology, Vol 136, 995-1002, Copyright © 1995 by Endocrine Society

ARTICLES

High level overexpression of glucose transporter-4 driven by an adipose- specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance

L Gnudi, E Tozzo, PR Shepherd, JL Bliss and BB Kahn
Harvard Thorndike Research Laboratory, Harvard Medical School, Boston, Massachusetts 02215.

High fat feeding is associated with impaired insulin action, an obese body composition, and down-regulation of glucose transporter-4 (GLUT4) expression in adipocytes. We recently showed that overexpression of GLUT4 selectively in adipocytes of transgenic mice using the aP2 (fatty acid-binding protein) promoter/enhancer results in enhanced glucose tolerance and adipocyte hyperplasia. Here, we fed these GLUT4- overexpressing transgenic mice a high fat (55%) or a low fat (10%) diet for 13-15 weeks to determine the role of alterations in GLUT4 expression in adipocytes in the development of insulin resistance and obesity, which are characteristic of high fat consumption. In nontransgenic mice, high fat feeding results in 45-50% reduction of GLUT4 levels in white and brown adipose tissue, with a parallel decrease in insulin-stimulated glucose transport. In transgenic mice receiving the low fat diet, GLUT4 is overexpressed 20-fold in white and 4-fold in brown adipose tissue. Glucose transport in epididymal adipocytes is increased 20-fold in the basal state and 6-fold in the insulin-stimulated state. Even after transgenic mice are fed a high fat diet, GLUT4 expression and glucose transport in their adipocytes remains 14- to 30-fold greater than that in nontransgenic mice receiving the same diet. Despite these marked effects at the adipose cell level, glucose tolerance is not improved, probably due to insulin resistance in skeletal muscle and liver, where the transgene is not expressed. During the low fat diet, transgenic mice have 80% more body lipid than nontransgenics. High fat feeding increases body lipid 76% and adipocyte size 65% in nontransgenic mice, but has no effect in transgenic mice. Thus, overexpression of GLUT4 selectively in adipocytes protects against a further increase in adiposity. Furthermore, by using a heterologous promoter, high level overexpression of GLUT4 can be maintained even under metabolic conditions where it is normally down-regulated in adipocytes. This overexpression results in markedly increased glucose transport at the cellular level, but adipose-specific GLUT4 overexpression does not prevent the decrease in glucose tolerance associated with high fat feeding.

This article has been cited by other articles:

				A. S. Metlakunta, M. Sahu, and A. Sahu Hypothalamic Phosphatidylinositol 3-Kinase Pathway of Leptin Signaling Is Impaired during the Development of Diet-Induced Obesity in FVB/N Mice Endocrinology, March 1, 2008; 149(3): 1121 - 1128. [Abstract] [Full Text] [PDF]

				J.-a Kim, Y. Wei, and J. R. Sowers Role of Mitochondrial Dysfunction in Insulin Resistance Circ. Res., February 29, 2008; 102(4): 401 - 414. [Abstract] [Full Text] [PDF]

				E. Carvalho, K. Kotani, O. D. Peroni, and B. B. Kahn Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E551 - E561. [Abstract] [Full Text] [PDF]

				M. Funaki, P. Randhawa, and P. A. Janmey Separation of Insulin Signaling into Distinct GLUT4 Translocation and Activation Steps Mol. Cell. Biol., September 1, 2004; 24(17): 7567 - 7577. [Abstract] [Full Text] [PDF]

				B. CANNON and J. NEDERGAARD Brown Adipose Tissue: Function and Physiological Significance Physiol Rev, January 1, 2004; 84(1): 277 - 359. [Abstract] [Full Text] [PDF]

				I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice J. Biol. Chem., December 17, 1999; 274(51): 36219 - 36225. [Abstract] [Full Text] [PDF]

				D. Chen and A. Garg Monogenic disorders of obesity and body fat distribution J. Lipid Res., October 1, 1999; 40(10): 1735 - 1746. [Abstract] [Full Text]

				A. Ibrahimi, A. Bonen, W. D. Blinn, T. Hajri, X. Li, K. Zhong, R. Cameron, and N. A. Abumrad Muscle-specific Overexpression of FAT/CD36 Enhances Fatty Acid Oxidation by Contracting Muscle, Reduces Plasma Triglycerides and Fatty Acids, and Increases Plasma Glucose and Insulin J. Biol. Chem., September 17, 1999; 274(38): 26761 - 26766. [Abstract] [Full Text] [PDF]

				M. D. McArthur, D. You, K. Klapstein, and D. T. Finegood Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E739 - E746. [Abstract] [Full Text] [PDF]

				B. A. Marshall, P. A. Hansen, N. J. Ensor, M. A. Ogden, and M. Mueckler GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E390 - E400. [Abstract] [Full Text] [PDF]

				J. S. Fisler and C. H. Warden Mapping of Mouse Obesity Genes: A Generic Approach to a Complex Trait J. Nutr., September 1, 1997; 127(9): 1909 - 1909. [Abstract] [Full Text]